Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
BMC Pharmacology & Toxicology
|
September 23, 2015
Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies
Martin Coenen, Annette Viktoria Hinze, Martin Mengel, et al.
Plos One
|
May 9, 2013
RIG-I detects triphosphorylated RNA of Listeria monocytogenes during infection in non-immune cells
Cristina Amparo Hagmann, Anna Maria Herzner, Zeinab Abdullah, et al.
European Journal of Immunology
|
July 6, 2011
Immunogenic cell death of human ovarian cancer cells induced by cytosolic poly(I:C) leads to myeloid cell maturation and activates NK cells
Kirsten Kübler, Carola tho Pesch, Nadine Gehrke, et al.
Diagnostics (Basel, Switzerland)
|
March 6, 2021
MR-Imaging and Histopathological Diagnostic Work-Up of Patients with Spontaneous Lobar Intracerebral Hemorrhage: Results of an Institutional Prospective Registry Study
Patrick Schuss, Christian Bode, Valeri Borger, et al.
The Journal of Infectious Diseases
|
July 21, 2022
Retinoic Acid-Inducible Gene I Activation Inhibits Human Respiratory Syncytial Virus Replication in Mammalian Cells and in Mouse and Ferret Models of Infection
Lara S U Schwab, Rubaiyea Farrukee, Jean-François Eléouët, et al.
Frontiers in Immunology
|
April 12, 2019
Human TLR8 Senses RNA From <i>Plasmodium falciparum</i>-Infected Red Blood Cells Which Is Uniquely Required for the IFN-γ Response in NK Cells
Christoph Coch, Benjamin Hommertgen, Thomas Zillinger, et al.
European Journal of Clinical Pharmacology
|
January 9, 2017
Who is a 'healthy subject'?-consensus results on pivotal eligibility criteria for clinical trials
Kerstin Breithaupt-Groegler, Christoph Coch, Martin Coenen, et al.
Journal of Cancer Research and Clinical Oncology
|
April 22, 2016
Phase I trial of dovitinib (TKI258) in recurrent glioblastoma
Niklas Schäfer, Gerrit H Gielen, Sied Kebir, et al.
BMC Family Practice
|
April 27, 2016
Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial
Julia Carolin Stingl, Katharina Luise Kaumanns, Katrin Claus, et al.
Vaccines
|
May 27, 2023
Potential of Nucleic Acid Receptor Ligands to Improve Vaccination Efficacy against the Filarial Nematode <i>Litomosoides sigmodontis</i>
Johanna F Scheunemann, Frederic Risch, Julia J Reichwald, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
BMC Pharmacology & Toxicology
|
September 23, 2015
Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies
Martin Coenen, Annette Viktoria Hinze, Martin Mengel, et al.
Plos One
|
May 9, 2013
RIG-I detects triphosphorylated RNA of Listeria monocytogenes during infection in non-immune cells
Cristina Amparo Hagmann, Anna Maria Herzner, Zeinab Abdullah, et al.
European Journal of Immunology
|
July 6, 2011
Immunogenic cell death of human ovarian cancer cells induced by cytosolic poly(I:C) leads to myeloid cell maturation and activates NK cells
Kirsten Kübler, Carola tho Pesch, Nadine Gehrke, et al.
Diagnostics (Basel, Switzerland)
|
March 6, 2021
MR-Imaging and Histopathological Diagnostic Work-Up of Patients with Spontaneous Lobar Intracerebral Hemorrhage: Results of an Institutional Prospective Registry Study
Patrick Schuss, Christian Bode, Valeri Borger, et al.
The Journal of Infectious Diseases
|
July 21, 2022
Retinoic Acid-Inducible Gene I Activation Inhibits Human Respiratory Syncytial Virus Replication in Mammalian Cells and in Mouse and Ferret Models of Infection
Lara S U Schwab, Rubaiyea Farrukee, Jean-François Eléouët, et al.
Frontiers in Immunology
|
April 12, 2019
Human TLR8 Senses RNA From <i>Plasmodium falciparum</i>-Infected Red Blood Cells Which Is Uniquely Required for the IFN-γ Response in NK Cells
Christoph Coch, Benjamin Hommertgen, Thomas Zillinger, et al.
European Journal of Clinical Pharmacology
|
January 9, 2017
Who is a 'healthy subject'?-consensus results on pivotal eligibility criteria for clinical trials
Kerstin Breithaupt-Groegler, Christoph Coch, Martin Coenen, et al.
Journal of Cancer Research and Clinical Oncology
|
April 22, 2016
Phase I trial of dovitinib (TKI258) in recurrent glioblastoma
Niklas Schäfer, Gerrit H Gielen, Sied Kebir, et al.
BMC Family Practice
|
April 27, 2016
Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial
Julia Carolin Stingl, Katharina Luise Kaumanns, Katrin Claus, et al.
Vaccines
|
May 27, 2023
Potential of Nucleic Acid Receptor Ligands to Improve Vaccination Efficacy against the Filarial Nematode <i>Litomosoides sigmodontis</i>
Johanna F Scheunemann, Frederic Risch, Julia J Reichwald, et al.
Page
of 7